Cite
Prognostic impact of TP53 mutation, monosomal karyotype, and prior myeloid disorder in nonremission acute myeloid leukemia at allo-HSCT
MLA
Noriko Doki, et al. “Prognostic Impact of TP53 Mutation, Monosomal Karyotype, and Prior Myeloid Disorder in Nonremission Acute Myeloid Leukemia at Allo-HSCT.” Bone Marrow Transplantation, vol. 56, no. 2, Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a98d5f1bd43239dd9cea8673259ef447&authtype=sso&custid=ns315887.
APA
Noriko Doki, Kazuteru Ohashi, Takashi Toya, Chizuko Hirama, Kota Yoshifuji, Hironori Harada, Yuho Najima, Kyoko Inamoto, Keisuke Oboki, Kazuhiko Kakihana, Megumi Akiyama, Daichi Sadato, Takeshi Kobayashi, Hisashi Sakamaki, Yoshiki Okuyama, Yuka Harada, Aiko Igarashi, & Kyoko Haraguchi. (2020). Prognostic impact of TP53 mutation, monosomal karyotype, and prior myeloid disorder in nonremission acute myeloid leukemia at allo-HSCT. Bone Marrow Transplantation, 56(2).
Chicago
Noriko Doki, Kazuteru Ohashi, Takashi Toya, Chizuko Hirama, Kota Yoshifuji, Hironori Harada, Yuho Najima, et al. 2020. “Prognostic Impact of TP53 Mutation, Monosomal Karyotype, and Prior Myeloid Disorder in Nonremission Acute Myeloid Leukemia at Allo-HSCT.” Bone Marrow Transplantation 56 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a98d5f1bd43239dd9cea8673259ef447&authtype=sso&custid=ns315887.